| Primary |
| Diabetes Mellitus |
83.3% |
| Type 2 Diabetes Mellitus |
16.7% |
|
| Myocardial Infarction |
14.3% |
| Abdominal Discomfort |
7.1% |
| Adverse Event |
7.1% |
| Blood Glucose Increased |
7.1% |
| Death |
7.1% |
| Diabetes Mellitus Inadequate Control |
7.1% |
| Dysphagia |
7.1% |
| Glycosylated Haemoglobin Increased |
7.1% |
| Incorrect Dose Administered |
7.1% |
| Malaise |
7.1% |
| Nausea |
7.1% |
| Renal Failure |
7.1% |
| Vomiting |
7.1% |
|
| Secondary |
| Hypertension |
50.0% |
| Diabetes Mellitus |
25.0% |
| Rheumatoid Arthritis |
25.0% |
|
| Death |
25.0% |
| Feeling Abnormal |
25.0% |
| Nausea |
25.0% |
| Renal Failure Acute |
25.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.7% |
| Diabetes Mellitus Non-insulin-dependent |
18.2% |
| Diabetes Mellitus |
16.9% |
| Drug Use For Unknown Indication |
4.6% |
| Type 2 Diabetes Mellitus |
4.1% |
| Hypertension |
3.8% |
| Pain |
3.8% |
| Rheumatoid Arthritis |
3.3% |
| Prophylaxis |
3.1% |
| Depression |
2.6% |
| Hypertonic Bladder |
2.6% |
| Hormone Replacement Therapy |
2.3% |
| Smoking Cessation Therapy |
2.3% |
| Psoriasis |
2.0% |
| Renal Cell Carcinoma |
2.0% |
| Thrombosis |
2.0% |
| Blood Cholesterol Abnormal |
1.8% |
| Osteoporosis |
1.8% |
| Angina Pectoris |
1.5% |
| B-cell Lymphoma |
1.5% |
|
| Weight Decreased |
28.8% |
| Blood Glucose Increased |
9.0% |
| Weight Increased |
9.0% |
| Myocardial Infarction |
8.1% |
| Surgery |
4.5% |
| Migraine |
3.6% |
| Nausea |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Depression |
2.7% |
| Drug Ineffective |
2.7% |
| Flushing |
2.7% |
| Injection Site Pain |
2.7% |
| Pain |
2.7% |
| Sepsis |
2.7% |
| Vision Blurred |
2.7% |
| Vomiting |
2.7% |
| Wheezing |
2.7% |
| Chest Pain |
1.8% |
| Diarrhoea |
1.8% |
| Drug Effect Decreased |
1.8% |
|
